Rezultati - Birgit Schoeberl
- Showing 1 - 15 results of 15
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation od Birgit Schoeberl, Anthony C. Faber, Danan Li, Mei‐Chih Liang, Katherine Crosby, Matthew Onsum, Olga Burenkova, Emily Pace, Zandra E. Walton, Lin Nie, Aaron Fulgham, Youngchul Song, Ulrik B. Nielsen, Jeffrey A. Engelman, Kwok‐Kin Wong
Izdano 2010Artigo -
11
MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors od Jonathan B. Fitzgerald, Bryan W. Johnson, Jason Baum, Sharlene Adams, Sergio Iadevaia, Jian Tang, Victoria Rimkunas, Lihui Xu, Neeraj Kohli, Rachel Rennard, Maja Razlog, Yang Jiao, Brian D. Harms, Kenneth J. Olivier, Birgit Schoeberl, Ulrik B. Nielsen, Alexey A. Lugovskoy
Izdano 2013Artigo -
12
Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3 od Charlotte F. McDonagh, Alexandra Huhalov, Brian D. Harms, Sharlene Adams, Violette Paragas, Shinji Oyama, Bo Zhang, Lia Luus, Ryan Overland, Stephanie A. Nguyen, Jinming Gu, Neeraj Kohli, Matt Wallace, Michael J. Feldhaus, Arthur J. Kudla, Birgit Schoeberl, Ulrik B. Nielsen
Izdano 2012Artigo -
13
An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells od Qing Sheng, Xinggang Liu, Eleanor Fleming, Karen Yuan, Huiying Piao, Jinyun Chen, Zeinab Moustafa, Roman K. Thomas, Heidi Greulich, Anna C. Schinzel, Sara Zaghlul, David Batt, Seth A. Ettenberg, Matthew Meyerson, Birgit Schoeberl, Andrew L. Kung, William C. Hahn, Ronny Drapkin, David M. Livingston, Joyce F. Liu
Izdano 2010Artigo -
14
Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer od Adam J. Camblin, Emily A. Pace, Sharlene Adams, Michael D. Curley, Victoria Rimkunas, Lin Nie, Gege Tan, Troy Bloom, Sergio Iadevaia, Jason Baum, Charlene Minx, Akos Czibere, Chrystal U. Louis, Daryl C. Drummond, Ulrik B. Nielsen, Birgit Schoeberl, J. Marc Pipas, Robert M. Straubinger, Vasileios Askoxylakis, Alexey A. Lugovskoy
Izdano 2018Artigo -
15
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121) od Birgit Schoeberl, Art Kudla, Kristina Masson, Ashish Kalra, Michael Curley, Gregory J. Finn, Emily Pace, Brian D. Harms, Jaeyeon Kim, Kearns Jeff, Aaron Fulgham, Olga Burenkova, Viara Grantcharova, Defne Yarar, Violette Paragas, Jonathan B. Fitzgerald, Marisa J. Wainszelbaum, Kip A. West, Sara Mathews, Rachel Nering, Bambang S. Adiwijaya, Gabriela Garcia, Bill Kubasek, Victor Moyo, Akos Czibere, Ulrik B. Nielsen, Gavin MacBeath
Izdano 2017Revisão
Iskalna orodja:
Sorodne teme
Cancer research
Biology
Cell biology
ERBB3
Receptor
Signal transduction
Cancer
Genetics
Internal medicine
Medicine
Neuregulin
Biochemistry
Epidermal growth factor receptor
ErbB
Immunology
Chemistry
PI3K/AKT/mTOR pathway
Pharmacology
Protein kinase B
Receptor tyrosine kinase
Gene
MAPK/ERK pathway
Antibody
Autocrine signalling
Breast cancer
Cell
Cell growth
Neuregulin 1
Activator (genetics)
Algorithm